Literature DB >> 9416499

What can we learn about human immunodeficiency virus infection from a study of lymphocytic choriomeningitis virus?

P Klenerman1, R M Zinkernagel.   

Abstract

The role of cytotoxic T lymphocytes (CTL) in human immunodeficiency virus (HIV) infection remains elusive. Since the discovery 10 years ago of high levels of specific CTL in this disease, some have argued that they play an important role in virus control, others that they drive disease progression through destruction of T helper cells, and others still that they play no obvious role at all. By contrast, the central role of CTL in murine lymphocytic choriomeningitis virus (LCMV) infection has been very clearly worked out through the use of in vivo depletion and adoptive transfer experiments, as well as knockout and transgenic mice. To interpret the possible roles for CTL in HIV, we have therefore made a comparison between what is known about CTL and their interaction with virus-infected cells in these two infections. This illustrates a potential critical role for these cells in both control of HIV replication and immune-mediated pathology, but one that is highly dependent on virus dose, distribution and dynamics.

Entities:  

Mesh:

Year:  1997        PMID: 9416499     DOI: 10.1111/j.1600-065x.1997.tb01003.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  13 in total

1.  Expression of CD28 and CD38 by CD8+ T lymphocytes in HIV-1 infection correlates with markers of disease severity and changes towards normalization under treatment. The Swiss HIV Cohort Study.

Authors:  P Bürgisser; C Hammann; D Kaufmann; M Battegay; O T Rutschmann
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

2.  HIV-1 dynamics revisited: biphasic decay by cytotoxic T lymphocyte killing?

Authors:  R A Arnaout; M A Nowak; D Wodarz
Journal:  Proc Biol Sci       Date:  2000-07-07       Impact factor: 5.349

Review 3.  Modeling T cell responses to antigenic challenge.

Authors:  Dominik Wodarz
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-10-01       Impact factor: 2.745

Review 4.  Viral escape mechanisms--escapology taught by viruses.

Authors:  M Lucas; U Karrer; A Lucas; P Klenerman
Journal:  Int J Exp Pathol       Date:  2001-10       Impact factor: 1.925

5.  The role of the cytotoxic T-lymphocyte response and virus cytopathogenicity in the virus decline during antiviral therapy.

Authors:  Vitaly V Ganusov
Journal:  Proc Biol Sci       Date:  2003-07-22       Impact factor: 5.349

6.  An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses.

Authors:  P André; M Groettrup; P Klenerman; R de Giuli; B L Booth; V Cerundolo; M Bonneville; F Jotereau; R M Zinkernagel; V Lotteau
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

7.  Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection.

Authors:  P J Goulder; M A Altfeld; E S Rosenberg; T Nguyen; Y Tang; R L Eldridge; M M Addo; S He; J S Mukherjee; M N Phillips; M Bunce; S A Kalams; R P Sekaly; B D Walker; C Brander
Journal:  J Exp Med       Date:  2001-01-15       Impact factor: 14.307

8.  Immunopathogenesis of human T-cell leukemia virus type-1-associated myelopathy/tropical spastic paraparesis: recent perspectives.

Authors:  Mineki Saito; Charles R M Bangham
Journal:  Leuk Res Treatment       Date:  2012-02-06

Review 9.  Neuroimmunological aspects of human T cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis.

Authors:  Mineki Saito
Journal:  J Neurovirol       Date:  2013-08-14       Impact factor: 3.739

Review 10.  Understanding Experimental LCMV Infection of Mice: The Role of Mathematical Models.

Authors:  Gennady Bocharov; Jordi Argilaguet; Andreas Meyerhans
Journal:  J Immunol Res       Date:  2015-10-21       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.